SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (8801)6/1/1998 9:26:00 AM
From: AlienTech  Read Replies (1) of 23519
 
LAKE MARY, Fla.--(BUSINESS WIRE)--June 1, 1998--Harvard Scientific Corp., (OTC Bul Bd:HVSF) a Nevada corporation, announced today that it has received notification from the U.S. Food and Drug Administration ("FDA") that their review of the company's Phase I submission data has been completed and the company may initiate Phase II clinical trials for its male erectile and sexual dysfunction treatment product.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News